. CDC advisers vote to narrow use of J&J vaccine due to concerns about rare blood clots « JO LEE MAGAZINE

NPR – The advisers said Thursday that vaccines from Pfizer and Moderna should be preferred by all adults, who may be at greater risk for developing severe blood clots from the J&J vaccine than those under age 18. Some committee members said the J&J vaccine should remain available for people who prefer it. A final decision on the J&J vaccine will come from CDC Director Rochelle Walensky. The director typically follows the recommendations of the agency’s advisers. The recommendation was prompted by the occurrence of a rare and sometimes fatal blood-clotting problem called thrombosis with thrombocytopenia syndrome (TTS).

Breaking News at NPR

World on the Run | Jo Lee Magazine

Comments are closed.